Grants8

Grant Information	Key Details	Eligibility & Funding
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional) PAR-25-317 Programme: National Institutes of Health (NIH)	The core objective of this grant is to advance scientific understanding of minority health and health disparities by funding research focused on family health, well-being, and resilience. This research aims to develop interventions at the interpersonal and family levels. Target Recipient Type: Primarily research organizations, including universities, non-profits, and certain for-profit entities, that conduct biomedical, clinical, population, behavioral, or social sciences research. Target Size: SECTOR-SPECIFIC in healthcare and social sciences. Geographic Scope: Projects must focus on families from NIH-designated populations experiencing health disparities in the United States. Foreign organizations are not eligible to apply for funding. Key Filtering Criteria: Research must involve family-level studies and address health disparities. Must include measures for at least two family members. Grant Frequency: This is a recurring funding opportunity, a reissue of a previous PAR (PAR-21-358).	Funding Up to None USD Deadline May 7, 2027, 5 p.m.	Details
NIH Brain Development Cohorts (NBDC) Biospecimen Access (X01 Clinical Trial Not Allowed) PAR-23-229 Programme: NIH Brain Development Cohorts (NBDC) Biospecimen Access Program	This grant provides investigators with access to biological samples from the Adolescent Brain Cognitive Development (ABCD) Study, the largest longitudinal study of brain development and child health in the U.S. The primary objective is to maximize the scientific potential of these biospecimens for conducting research on child and adolescent health. This is a SECTOR-SPECIFIC opportunity, targeting research institutions and scientists focused on adolescent health, neurodevelopment, and related fields. Geographic scope is global, open to both U.S. and non-U.S. entities. Key filtering criteria include the need for specific biospecimens for research and having secured independent funding to conduct the proposed research. This is a recurring resource access program, active with multiple submission windows until May 2026.	Funding Up to None USD Deadline May 5, 2026, 9 p.m.	Details
Erasmus Charter for Higher Education 44774210ERASMUSECHECharter1645574400000 Programme: Erasmus Charter for Higher Education	GRANT PURPOSE AND TARGET The core objective of this call is to accredit Higher Education Institutions (HEIs) so they can participate in Erasmus+ Programme activities, such as learning mobility and cooperation projects. Target recipients are Higher Education Institutions (public or private). Organization size is not specified. This is a SECTOR-SPECIFIC grant, exclusively for the Education sector. Geographic scope includes Erasmus+ Programme Countries (EU Member States, EEA countries, associated countries like Turkey, North Macedonia, Serbia), countries in negotiations for association (specifically Switzerland, with conditional validity), and Western Balkans third countries not associated (Albania, Bosnia and Herzegovina, Kosovo, Montenegro). Key filtering criteria include being a recognized HEI and being established in one of the eligible countries. This is a recurring grant opportunity with multiple annual cut-off dates, part of the broader Erasmus+ Programme.	Funding Up to None None Deadline Jan. 27, 2026, 4 p.m.	Details
NEI Collaborative Clinical Vision Research: Chair's Grant (UG1-Clinical Trial Required) PAR-23-209 Programme: National Institutes of Health (NIH)	The core objective of this grant is to support investigator-initiated, complex, high-resource, or high-safety-risk clinical trials that evaluate interventions for screening, diagnosing, preventing, or treating vision disorders, or compare the effectiveness of established interventions. This specific Notice of Funding Opportunity (NOFO) focuses on the Chair's Grant, which outlines the scientific rationale, study aims, and overall significance of the research project. - Target recipients: Higher Education Institutions, Nonprofits, For-Profit Organizations (including Small Businesses), Local Governments, Federal Government agencies, and other organizational types including foreign entities. - Size: Open to organizations of various sizes, from small businesses to larger for-profit entities and government agencies. - Sector: SECTOR-SPECIFIC (Healthcare, specifically Vision Research/Ophthalmology). - Geographic scope: United States and Non-U.S. (Foreign Institutions) are eligible. - Key filtering criteria: Must propose an NIH-defined clinical trial focused on vision disorders, and the trial must be complex or involve high resource or safety risks. - Grant frequency: Reissue of a previous opportunity (PAR-21-041), indicating it is a recurring program. - Program context: This Chair's Grant is typically one component of a larger, multi-entity study funded through NEI's UG1 cooperative agreement awards, often involving companion Coordinating Center and Resource Center grants.	Funding Up to None USD Deadline Jan. 25, 2026, 10 p.m.	Details
Funding opportunity: Environmental Literacy for Community Resilience in the Gulf ELP Programme: Environmental Literacy Program	The core objective of this funding opportunity is to enhance environmental literacy and foster community resilience within the Gulf region. This grant is SECTOR-SPECIFIC, focusing on environmental education and community development initiatives. The geographic scope is limited to the Gulf region. Key filtering criteria for initial screening include a clear focus on environmental literacy, community resilience, and a demonstrated presence or project scope in the Gulf. This opportunity appears to be part of the recurring Environmental Literacy Program (ELP) offered by NOAA.	Funding Up to None USD Deadline Sept. 30, 2026, 4 a.m.	Details
Deeptech Akcelerator Deeptech Akcelerator Programme: European Funds for Modern Economy	Core objective: Development of startups within an acceleration program delivered by the Podkarpackie Innovation Centre. Target recipients: Start-ups, micro and small enterprises. MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': This grant is SECTOR-SPECIFIC (health, innovative food, ICT) and also SECTOR-AGNOSTIC. Geographic scope: Project implementation in Poland, with territorial reach extending to Poland and abroad. Key filtering criteria: Organization type, size (micro/small), legal form (capital company), and operating age (up to 5 years). Grant frequency: Recurring. The program plans for 3 calls resulting in 5 acceleration rounds, targeting 48 startups. This indicates a multi-round program context.	Funding Up to None PLN Deadline Feb. 11, 2026, 3:30 p.m.	Details
NIDA Core "Center of Excellence" Grant Program (P30 Clinical Trial Optional) PAR-23-049 Programme: National Institute on Drug Abuse (NIDA)	Establish NIDA Core 'Centers of Excellence' (P30) to enhance and extend existing research in substance use/misuse, addiction, and HIV. Facilitate interdisciplinary collaborations and promote new research directions. Provide research opportunities for new and early-career investigators. Target recipient type: Higher education institutions, non-profits, for-profit organizations (small and large), local and federal governments, U.S. territories/possessions. Target size: Organizations capable of supporting a minimum of 3 separate federally funded research project grants, with at least 2 distinct PDs/PIs. SECTOR-SPECIFIC: Health/Biomedical Research (Substance Use/Misuse, Addiction, HIV). Geographic scope: United States. Foreign institutions are not eligible to apply as the lead organization, but foreign components of U.S. organizations are allowed. Key filtering criteria: Existing federal research funding base, ability to foster interdisciplinary collaboration, commitment to new investigator development, U.S. institutional base. Grant frequency: Recurring (multiple annual deadlines). Program context: Reissue of previous program (PAR-20-267).	Funding Up to None USD Deadline Sept. 25, 2025, 5 p.m.	Details
Call for Proposals (Non-Competitive) for Feasibility Studies and Demonstration Projects leveraging space-based services for smart cities. 1-10494 Programme: ESA Business Applications	This grant invites proposals for Feasibility Studies and Demonstration Projects that use space-based services and applications to solve challenges in the smart cities sector. It targets companies and organizations of varying sizes, with a focus on those with business, technical, and financial expertise. This is a SECTOR-SPECIFIC grant, focused on urban development and smart city solutions. The geographic scope for applicants is limited to specific ESA Member States and Cooperating States. It's an ongoing 'Open Call' with defined application windows, part of ESA's broader Business Applications program.	Funding Up to None EUR Deadline Sept. 30, 2025, 11:59 p.m.	Details
Reduction of property tax for buildings with low E-level VLAIO-Vermindering onroerende voorheffing Programme: Vlaamse Belastingdienst fiscal measures	This grant provides a property tax reduction for owners of buildings in Flanders. - The core objective is to incentivize (partial) reconstruction or major energetic renovation projects that result in highly energy-efficient buildings with a low 'E-peil'. - Target recipient type: Owners of buildings (individuals, businesses, public entities). - Target recipient size: Any size of owner. - This grant is SECTOR-SPECIFIC (Construction, Real Estate, Energy Efficiency). - Geographic scope: Flanders, Belgium. - Key filtering criteria: Ownership of a building, completion of eligible construction/renovation, achievement of a low 'E-peil', and a valid building permit application before October 1, 2025. - Grant frequency: Recurring fiscal measure, but being phased out for new applications.	Funding Up to None EUR Deadline Sept. 30, 2025, 10:59 p.m.	Details
Multidisciplinary Studies of HIV/AIDS and Aging (R01 Clinical Trial Optional) PAR-25-354 Programme: National Institutes of Health (NIH)	This grant aims to advance research at the intersection of HIV and aging. Its core objective is to improve understanding of the biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment. Additionally, it seeks to enhance approaches for testing, preventing, and treating HIV infection, and managing related comorbidities in diverse populations and settings by applying current aging science approaches. Explicit identification of target recipient type and size: Organizations capable of conducting biomedical, social, and behavioral research. MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC (Healthcare, Medical Research) Geographic scope and any location requirements: United States and Non-U.S. (Foreign Organizations) are eligible. Key filtering criteria for initial grant screening: Proposed research must be consistent with the HIV/AIDS Research Priorities outlined by NIH's Office of AIDS Research (OAR), specifically NOT-OD-20-018. Applications not aligned will not be reviewed. Grant frequency and program context: Reissue of PAR-24-091, indicating a recurring opportunity. This program addresses the significant and growing population of older adults living with HIV and the complex interplay between HIV infection, its treatment, and the aging process.	Funding Up to None USD Deadline Jan. 7, 2027, 5 p.m.	Details

The core objective of this grant is to support investigator-initiated, complex, high-resource, or high-safety-risk clinical trials that evaluate interventions for screening, diagnosing, preventing, or treating vision disorders, or compare the effectiveness of established interventions. This specific Notice of Funding Opportunity (NOFO) focuses on the Chair's Grant, which outlines the scientific rationale, study aims, and overall significance of the research project. - Target recipients: Higher Education Institutions, Nonprofits, For-Profit Organizations (including Small Businesses), Local Governments, Federal Government agencies, and other organizational types including foreign entities. - Size: Open to organizations of various sizes, from small businesses to larger for-profit entities and government agencies. - Sector: SECTOR-SPECIFIC (Healthcare, specifically Vision Research/Ophthalmology). - Geographic scope: United States and Non-U.S. (Foreign Institutions) are eligible. - Key filtering criteria: Must propose an NIH-defined clinical trial focused on vision disorders, and the trial must be complex or involve high resource or safety risks. - Grant frequency: Reissue of a previous opportunity (PAR-21-041), indicating it is a recurring program. - Program context: This Chair's Grant is typically one component of a larger, multi-entity study funded through NEI's UG1 cooperative agreement awards, often involving companion Coordinating Center and Resource Center grants.

This grant aims to advance research at the intersection of HIV and aging. Its core objective is to improve understanding of the biological, clinical, and socio-behavioral aspects of aging through the lens of HIV infection and its treatment. Additionally, it seeks to enhance approaches for testing, preventing, and treating HIV infection, and managing related comorbidities in diverse populations and settings by applying current aging science approaches.

Explicit identification of target recipient type and size: Organizations capable of conducting biomedical, social, and behavioral research.
MUST state if grant is 'SECTOR-SPECIFIC' or 'SECTOR-AGNOSTIC': SECTOR-SPECIFIC (Healthcare, Medical Research)
Geographic scope and any location requirements: United States and Non-U.S. (Foreign Organizations) are eligible.
Key filtering criteria for initial grant screening: Proposed research must be consistent with the HIV/AIDS Research Priorities outlined by NIH's Office of AIDS Research (OAR), specifically NOT-OD-20-018. Applications not aligned will not be reviewed.
Grant frequency and program context: Reissue of PAR-24-091, indicating a recurring opportunity. This program addresses the significant and growing population of older adults living with HIV and the complex interplay between HIV infection, its treatment, and the aging process.

You can filter by below criteria

Grants